Company Name: Bellicum Pharmaceuticals, Inc.

Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of cellular immunotherapies for hematological cancers, solid tumors and orphan inherited blood disorders.

Ticker Symbol: BLCM (NASDAQ)

Company Website: www.bellicum.com

Social Media: Bellicum Pharmaceuticals LinkedIn

Headquarters: Houston, Texas